Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Ewing Sarcoma · Colorectal Adenocarcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • HonorHealth Research Institute, Scottsdale, Arizona, United States

  • Precision NextGen Oncology and Research, Beverly Hills, California, United States

    Contact: Study coordinator (Francisco Capilla) · Franciscoc@nextgenonc.com · 424-777-0708
    Contact: Principal Investigator (Kamalesh Sankhala, MD)
  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (Heather Lewis) · healewis@coh.org · 626-256-4673
    Contact: Study coordinator (New Patient Services Coordinator) · newpatientref@coh.org · 1-800-826-4673
    Contact: Principal Investigator (Marwan Fakih, MD)
  • Valkyrie Clinical Trials, Los Angeles, California, United States

    Contact: Study coordinator (Carla Collier) · carla.collier@valkyrieclinicaltrials.com
    Contact: Principal Investigator (David Berz, MD)
  • University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California, United States

  • University of California, San Francisco (UCSF), San Francisco, California, United States

    Contact: Study coordinator (Lisa Tan) · lisa.tan@ucsf.edu · 415-866-7866
    Contact: Principal Investigator (Varun Monga, MD)
  • Sarcoma Oncology Center, Santa Monica, California, United States

    Contact: Study coordinator (Victoria Chua-Alcala) · vchua@sarcomaoncology.com · 310-552-9999
    Contact: Principal Investigator (Sant P Chawla, MD)
  • University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Michaela Riley) · michaela.riley@cuanschutz.edu
    Contact: Principal Investigator (Christopher Lieu, MD)
  • Emory University - Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Kimberly Homere) · kimberly.homere@emory.edu · 404-778-6583
    Contact: Principal Investigator (Olatunji Alese, MD)
  • The University of Chicago, Chicago, Illinois, United States

  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Myron Hepner) · mhepner@med.umich.edu
    Contact: Principal Investigator (Rashmi Chugh, MD)
  • START Midwest Michigan, PC, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Julie Burns) · julie.burns@startmidwest.com · 616-954-5559
    Contact: Study coordinator (Leland Rouse) · leland.rouse@startmidwest.com
    Contact: Principal Investigator (Nehal Lakhani, MD)
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Care Advisors) · 833-675-5437
    Contact: Principal Investigator (Emily Slotkin, MD)
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Michael D Deel, MD) · michael.deel@cchmc.org · 513-636-3200
    Contact: Study coordinator (Lori Backus, BA) · Lori.backus@cchmc.org · 513-636-2047
    Contact: Principal Investigator (Michael D Deel, MD)
  • Cleveland Clinic, Cleveland, Ohio, United States

  • Oregon Health & Science University, Portland, Oregon, United States

    Contact: Study coordinator (Zach Nelson) · nelsonz@ohsu.edu · 503-494-0833
    Contact: Principal Investigator (Michael Heinrich, MD)
  • Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Matthew Stein) · steinm3@chop.edu · 267-425-3169
    Contact: Principal Investigator (Theodore Laetsch, MD)
  • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Sarcoma Research) · SarcomaResearch@uphs.upenn.edu
    Contact: Principal Investigator (Lee Hartner, MD)
  • Vanderbilt University School of Medicine, Nashville, Tennessee, United States

    Contact: Study coordinator (Samrah Ahmed) · samrah.ahmed@vumc.org · 615.936.9598
    Contact: Principal Investigator (Elizabeth Davis, MD)
  • UT MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Emily Scott) · EMScott1@mdanderson.org · (713) 745-2243
    Contact: Principal Investigator (David Hong, MD)
  • NEXT Oncology, San Antonio, Texas, United States

  • University of Virginia, Charlottesville, Virginia, United States

    Contact: Study coordinator (Sarah Sommer) · ss2vz@uvahealth.org · 434-924-7613
    Contact: Principal Investigator (Ludimila Cavalcante, MD)
  • NEXT Oncology - Virginia, Fairfax, Virginia, United States

    Contact: Study coordinator (Anthony Young) · ayoung@nextoncology.com · 703-783-4536
    Contact: Principal Investigator (Alexander Spira, MD)
  • Centre Leon Berard, Lyon, France

    Contact: Principal Investigator (Mehdi Brahmi, MD)
  • Gustave Roussy, Villejuif, France

    Contact: Principal Investigator (Pablo Berlanga, MD)
  • La Fondazione e l'Istituto di Candiolo, Candiolo, Italy

    Contact: Principal Investigator (Sandra Aliberti, MD)
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Principal Investigator (Salvatore Provenzano, MD)
    Contact: Principal Investigator (Roberto Luksch, MD)
  • University Medical Center Groningen, Groningen, Netherlands

    Contact: Principal Investigator (Jacco de Haan, MD)
  • Academisch Ziekenhuis Leiden, Leiden, Netherlands

    Contact: Principal Investigator (André (Hans) Gelderblom, MD)
  • Hospital Universitario Vall d'Hebron, Barcelona, Spain

    Contact: Principal Investigator (Elena Elez, MD)
  • Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    Contact: Principal Investigator (Ana Sebio Garcia, MD)
  • Hospital Clinico San Carlos, Madrid, Spain

    Contact: Principal Investigator (Antonio Casado Herraez)
  • Great North Children's Hospital, London, United Kingdom

    Contact: Principal Investigator (Quentin Campbell-Hewson, MD)
  • University College London Hospital, London, United Kingdom

    Contact: Principal Investigator (Sandra Strauss, MD)
  • The Royal Marsden NHS Foundation Trust, London, United Kingdom

    Contact: Principal Investigator (Andrea Napolitano, MD)
  • Royal Manchester Children's Hospital, Manchester, United Kingdom

    Contact: Principal Investigator (Bernadette Maria Dymphna Brennan)
מובילי המחקר
  • Clinical Lead

    Study Director

    Inhibrx Biosciences, Inc